Form 6-K — CureVac N.V.: dievini, KfW and Dietmar Hopp amended the KfW dievini Shareholders' Agreement (2022)

Summary

A Form 6-K report of foreign private issuer filed by CureVac N.V. with the U.S. Securities and Exchange Commission for the month of January, 2022, Commission File Number 001-39446. It states that on January 13, 2022 dievini Hopp BioTech holding GmbH & Co. KG, Kreditanstalt für Wiederaufbau, Mr. Dietmar Hopp and DH-LT Investments GmbH amended the shareholders' agreement first entered into on June 16, 2020. The amendment is filed as Exhibit 99.1, a Second Amendment to the Shareholders' Agreement dated January 13, 2022. The information is incorporated by reference into Form F-3, File No. 333-259613.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Form 6-K — CureVac N.V.: dievini, KfW and Dietmar Hopp amended the KfW dievini Shareholders' Agreement (2022).” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-cvac-6-k-filed2022-01-13-0001104659-22-004038-9e5e113494/, SHA-256 c64331c773b8aee845342b3eefc210843c151b9264cc316905a9b91dcec3abad.

Full text

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE
ISSUER

PURSUANT TO RULE 13a-16
OR 15d-16 OF THE

SECURITIES EXCHANGE ACT
OF 1934

For the month of January, 2022

Commission File Number: 001-39446

CureVac N.V.

( Exact Name of Registrant as Specified in Its
Charter )

Friedrich-Miescher-Strasse 15, 72076

Tübingen, Germany

+49 7071 9883 0

(Address of principal executive office)

Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F | x | Form 40-F | ¨

Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes | ¨ | No | x

Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes | ¨ | No | x

On January 13, 2022, dievini Hopp BioTech holding GmbH & Co. KG,
or dievini, Kreditanstalt für Wiederaufbau, or KfW, Mr. Dietmar Hopp, and DH-LT Investments GmbH amended the shareholders’
agreement, or the KfW dievini Shareholders’ Agreement, which KfW, dievini and Mr. Dietmar Hopp entered into on June 16, 2020, and,
subsequently was amended to include DH-LT Investments GmbH, and is filed here as Exhibit 99.1.

The information included in this Form
6-K (including Exhibits 99.1) is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No.
333-259613).

SIGNATURES

Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

CUREVAC N.V.
By: | /s/ Franz-Werner Haas, LLD, LLM
Chief Executive Officer

Date: January 13, 2022

EXHIBIT INDEX

EXHIBIT
 NO. | DESCRIPTION
99.1 | Second Amendment to the Shareholders’ Agreement
 among Kreditanstalt für Wiederaufbau, Dievini Hopp BioTechholding GmbH & Co KG and Mr Dietmar Hopp, dated January 13, 2022.

File and source

File: SEC_CVAC_6-K_filed2022-01-13_0001104659-22-004038.htm
Size: 14,536 bytes
SHA-256: c64331c773b8aee845342b3eefc210843c151b9264cc316905a9b91dcec3abad
Our copy: SEC_CVAC_6-K_filed2022-01-13_0001104659-22-004038.htm
Original: www.sec.gov